Effect of a Postbiotic Supplementation in Overweight and Obese Subjects: A Randomized Controlled Trial (PARABIOTICS-2).

NCT07165431 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 114

Last updated 2026-02-19

No results posted yet for this study

Summary

The principal objective of this project is to evaluate the effect of a postbiotic supplement (inactivated microorganism) on body composition and other physiological and metabolic parameters related to excess body weight in overweight or obese adult men and women, as well as to determine changes in the gut microbiota associated with these outcomes.

Specific objectives are focus on evaluate the effect of the intervention on the following parameters:

* Changes in body weight and composition.
* Changes in glucose tolerance.
* Changes in gut microbiota (metagenomics).
* Changes in urinary and serum metabolites.
* Changes in routine biochemical variables related to carbohydrate and lipid metabolism, as well as liver parameters.
* Changes in specific markers involved in obesity pathology, such as insulin, leptin, adiponectin, and cytokines MCP-1, TNF, CRP, and others.
* Adherence to the nutritional recommendations and the gummy containing postbiotic formula.
* Changes in the level of physical activity.

Target sample size is 114 subjects, including a 10% of drop out.

Participants will be allocated in two groups for 12 weeks:

* Experimental group (n=57): nutritional recommendations + postbiotic supplement/gummy.
* Placebo group (n=57): nutritional recommendations + placebo supplement/gummy.

Participants will visit the nutritional intervention unit at weeks 1 and 12. A follow-up phone call will be conducted at week 6.

Conditions

  • Nutrition, Healthy
  • Weight Loss
  • Overweight and Obesity

Interventions

DIETARY_SUPPLEMENT

Postbiotic + nutritional recommendations

Study participants will consume daily one gummy containing a postbiotic formulation, along with adherence to healthy nutritional recommendations for 12 weeks.

DIETARY_SUPPLEMENT

Placebo + nutritional recommendations

Study participants will consume daily one gummy containing a placebo formulation, along with adherence to healthy nutritional recommendations for 12 weeks.

Sponsors & Collaborators

  • Clinica Universidad de Navarra, Universidad de Navarra

    lead OTHER

Principal Investigators

  • Paula Aranaz, PhD · Center for Nutrition Research

  • Fermín Milagro, PhD · Center for Nutrition Research

  • Idoia Ibero, PhD · Center for Nutrition Research

  • Blanca Martínez · Center for Nutrition Research

  • María Goñi · Center for Nutrition Research

  • Salomé Pérez · Center for Nutrition Research

  • Verónica Ciaurriz · Center for Nutrition Research

  • Ana Lorente · Center for Nutrition Research

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-12-01
Primary Completion
2026-05-30
Completion
2026-06-30

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07165431 on ClinicalTrials.gov